Cargando…
Prognostic Value of Mitotic Index and Bcl2 Expression in Male Breast Cancer
The incidence of male breast cancer (MBC) is rising. Current treatment regimens for MBC are extrapolated from female breast cancer (FBC), based on the assumption that FBC prognostic features and therapeutic targets can be extrapolated to MBC. However, there is yet little evidence that prognostic fea...
Autores principales: | Lacle, Miangela M., van der Pol, Carmen, Witkamp, Arjen, van der Wall, Elsken, van Diest, Paul J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3613416/ https://www.ncbi.nlm.nih.gov/pubmed/23573235 http://dx.doi.org/10.1371/journal.pone.0060138 |
Ejemplares similares
-
Prognostic models in male breast cancer
por: van der Pol, Carmen C., et al.
Publicado: (2016) -
Expression of Connective Tissue Growth Factor in Male Breast Cancer: Clinicopathologic Correlations and Prognostic Value
por: Lacle, Miangela M., et al.
Publicado: (2015) -
Chromosome 17 copy number changes in male breast cancer
por: Lacle, Miangela M., et al.
Publicado: (2015) -
Cytoplasmic DDX3 as prognosticator in male breast cancer
por: van der Pol, Carmen C., et al.
Publicado: (2021) -
Pathology of hereditary breast cancer
por: van der Groep, Petra, et al.
Publicado: (2011)